Skip to content

NAD+evidence-first

The NAD Review
menu

evidence_review

How Long Does NAD+ IV Therapy Last?

Clinics quote 7–14 days, but that number is practitioner convention, not trial-derived. Here's what's actually known about how long an NAD+ IV lasts.

Ask a clinic how long an NAD+ IV "lasts" and you'll usually hear a confident range — often 7 to 14 days — followed by a recommendation to come back for a maintenance drip every couple of weeks after an initial "loading" series. It sounds precise. It isn't. That number is a practitioner convention built around a billing and scheduling cadence, not a figure that falls out of any human trial. The honest answer to "how long does it last?" is more uncomfortable: nobody really knows, because the studies that would tell you have not been done.

This article is upfront about that gap. We'll separate the three different things people mean by "how long it lasts" — how long NAD+ stays elevated, how long any effect lasts, and how often clinics tell you to return — and be clear about which of those rests on data (almost none) and which rests on convention (almost all of it). NAD+ IV is not an FDA-approved treatment for anything, and nothing here is medical advice.

Three different questions hide inside "how long does it last?"

The phrase is ambiguous, and the ambiguity is where the marketing does its work. Pull it apart:

  1. How long does the NAD+ itself stay elevated in your body? A pharmacokinetic question.
  2. How long does any felt benefit last? An outcome question.
  3. How long until the clinic says you need another drip? A scheduling question.

The "7–14 days" answer is really answering question 3 — and then borrowing the credibility of questions 1 and 2, which it can't actually support.

// What 'lasts 7–14 days' really tracks

  1. // During infusion (2–6 h)

    NAD+ metabolized fast

    The one human pilot found free NAD+ largely undetectable in blood for hours as the body broke it down.

  2. // Hours–days after

    Duration unpublished

    No human study charts how long NAD+ stays elevated after a drip. NAD+ is a fast-turnover coenzyme, not a slow-draining reservoir.

  3. // 1–4 weeks

    Clinic maintenance interval

    This rebooking cadence is what gets reported as 'how long it lasts' — a scheduling convention, not a measured decay curve.

  4. // Benefit duration

    Nothing to measure

    No randomized trial shows an IV NAD+ benefit, so there is no benefit-duration to quote in the first place.

The '7–14 days' figure is a maintenance scheduling interval presented as pharmacology. Neither the NAD+ elevation nor any benefit has been tracked over days in a human IV trial.

Question 1: how long does NAD+ stay up? (Barely studied)

You'd think the duration of the NAD+ rise after an infusion would be well characterized. It isn't. There is essentially one published human study that tracked what happens to NAD+ during an IV infusion: a 2019 pilot that measured the plasma and urine NAD+ metabolome across a 6-hour drip1. Its most striking finding cuts directly against the "lasts for days" framing — free NAD+ was largely not detectable in the bloodstream for hours, as the body rapidly metabolized the infused NAD+ into its breakdown products1.

That single study only covered the infusion window itself; it did not follow participants for days afterward to chart how long any elevation persisted. So the literal pharmacokinetic question — "how many days does my NAD+ stay above baseline after a drip?" — has no published human answer. What we do know from the broader biology is that NAD+ turns over quickly in cells; it's a coenzyme in constant flux, continuously synthesized and consumed2. A one-time bolus isn't a reservoir that drains slowly over two weeks — it's fuel that gets used.

Even the oral-precursor data, which is far better characterized, points the same direction: when nicotinamide riboside augmented the aged human muscle NAD+ metabolome, the elevation was a feature of ongoing daily dosing, not a single dose that lingered3. Raising NAD+ and keeping it raised takes continuous input. That's the opposite of the "one drip lasts two weeks" mental model.

Question 2: how long does the benefit last? (No benefit has been proven to begin with)

This is the part that makes the durability question almost moot. To ask "how long does the benefit last," you first need a benefit that's been demonstrated in a controlled trial — and for IV NAD+, that doesn't exist. There is no randomized controlled trial showing intravenous NAD+ improves energy, focus, recovery, mood, or any aging-related outcome in humans. The Grant pilot measured biochemistry, not how anyone felt1.

And the sobering signal from the oral-precursor trials — the ones that do have outcome data — is that raising NAD+ often doesn't translate into felt benefits at all. NR raised the muscle NAD+ metabolome without improving muscle bioenergetics or performance3; a placebo-controlled NR trial in older adults with mild cognitive impairment raised NAD+ but left cognition unchanged4; and even NMN's most-cited positive result (improved insulin sensitivity in prediabetic women) was narrow and contested5. If the well-studied oral routes struggle to convert higher NAD+ into something you can feel, asking "how many days does the IV benefit last" is asking how long an effect persists that hasn't been shown to occur. The honest answer is that there's no benefit-duration to measure.

Question 3: the real source of "7–14 days" — clinic scheduling

So where does the specific 7-to-14-day number come from? From the clinic's protocol, not your bloodstream. The standard commercial model is a "loading" series of several infusions close together (often 4–10 sessions over a couple of weeks), followed by "maintenance" drips every 1–4 weeks. That maintenance interval is the "how long it lasts" number — it's the rebooking cadence, reverse-engineered into a duration claim.

There's nothing inherently sinister about a scheduling convention; lots of wellness services run on them. The problem is presenting a billing rhythm as if it were pharmacology. The interval isn't anchored to a measured decay curve of NAD+ or of any outcome — because, as above, those curves haven't been published for IV NAD+. The cadence is set by what's practical and what sustains a course of visits, then dressed in physiological language.

What actually influences how you feel after a drip

If people sometimes report feeling different for a stretch after an infusion, several non-NAD-specific factors are worth naming honestly:

  • Hydration and rest. A 2–6 hour IV delivers fluid and forces you to sit still for hours — both of which can make people feel better independent of NAD+.
  • Expectation and cost. A premium, effortful, expensive ritual produces real expectation effects; without a placebo arm, none of the clinic reports can separate that from a drug effect.
  • Regression to the mean. People often book a drip when they feel run-down; feeling better days later may simply be recovery that would have happened anyway.

None of these require NAD+ to "last" two weeks. They're reasons a single session might feel worthwhile to some people — but they're not evidence the infused NAD+ is still working days later.

So how should you think about it?

  • As pharmacology: the duration of the NAD+ rise after an IV is essentially uncharacterized in humans; the one study suggests NAD+ is metabolized fast, not stockpiled12.
  • As benefit: there's no proven IV benefit, so there's no benefit-duration to quote.
  • As scheduling: "7–14 days" is a maintenance interval — a convention — presented as a physiological fact.
  • As spending: a loading-plus-maintenance course can run into the low thousands of dollars for an unproven delivery route. We break the pricing and evidence down in NAD+ IV therapy: evidence, benefits & cost.

If your goal is simply keeping NAD+ elevated, the biology argues for consistent input rather than periodic boluses — which is the logic behind daily oral precursors, not intermittent drips (we compare the routes' actual evidence in NAD+ injections: what the research shows). And if you're judging a drip by photos or a "glow," read our honest look at the NAD+ before-and-after claims first.

Bottom line

"How long does an NAD+ IV last?" has a tidy-sounding answer — 7 to 14 days — that is mostly a clinic scheduling convention, not a trial-derived fact. The one human IV study measured a 6-hour infusion and found NAD+ wasn't even readily detectable in blood for hours1, no study has charted how long the elevation persists afterward, and no controlled trial has shown an IV benefit whose duration could be measured at all14. NAD+ turns over fast in the body2, and keeping it raised takes continuous input rather than a fortnightly top-up3. Treat the "lasts two weeks" claim as a rebooking interval dressed in physiology — and weigh the cost accordingly. For the full evidence picture, start with our NAD+ therapy pillar and compare vetted options on our best NAD+ hub.

Frequently asked questions

How long does NAD+ IV therapy last?

Clinics commonly quote 7 to 14 days, but that figure is a scheduling convention — the maintenance rebooking interval — not a trial-derived fact. No published human study has charted how long NAD+ stays elevated after an infusion, and no controlled trial has shown an IV NAD+ benefit whose duration could be measured. The one human IV study found free NAD+ wasn't even readily detectable in blood for hours during the drip.

Does a single NAD+ drip keep your NAD+ levels up for weeks?

There's no human evidence that it does. NAD+ is a fast-turnover coenzyme that cells continuously make and consume, not a reservoir that drains slowly. The only human IV study found NAD+ was rapidly metabolized during the infusion, and even well-studied oral precursors require continuous daily dosing to keep NAD+ elevated — which argues against a single drip lasting two weeks.

Why do clinics say you need a drip every 1–2 weeks?

That interval is a maintenance schedule, typically following an initial 'loading' series of several infusions. It's set by what's practical for a course of visits, not by a measured decay curve of NAD+ or of any outcome — because those curves haven't been published for IV NAD+. The rebooking cadence is essentially what gets reported as 'how long it lasts.'

If I feel better for a while after a drip, isn't that the NAD+ lasting?

Not necessarily. A 2–6 hour IV delivers hydration and forced rest, an expensive ritual produces real expectation effects, and people often book a drip when they're run-down (so later improvement may be normal recovery). Without a placebo-controlled trial, none of the clinic reports can attribute a lingering effect to the infused NAD+ itself.

How often would I actually need NAD+ IV therapy?

There's no evidence-based answer, because there are no outcome trials to anchor a frequency. Clinics typically recommend a loading series plus maintenance drips every 1–4 weeks, which can run into the low thousands of dollars for an unproven delivery route. If the goal is simply higher NAD+, the biology favors consistent daily input over intermittent infusions.

References

  1. Grant R, Berg J, Mestayer R, et al. (2019). A Pilot Study Investigating Changes in the Human Plasma and Urine NAD+ Metabolome During a 6 Hour Intravenous Infusion of NAD+.. Frontiers in Aging Neuroscience. https://pubmed.ncbi.nlm.nih.gov/31572171/
  2. Covarrubias AJ, Perrone R, Grozio A, Verdin E (2021). NAD+ metabolism and its roles in cellular processes during ageing.. Nature Reviews Molecular Cell Biology. https://pubmed.ncbi.nlm.nih.gov/33353981/
  3. Elhassan YS, Kluckova K, Fletcher RS, et al. (2019). Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD+ Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures.. Cell Reports. https://pubmed.ncbi.nlm.nih.gov/31412242/
  4. Orr ME, Kotwal A, Justice JN, et al. (2024). A randomized placebo-controlled trial of nicotinamide riboside in older adults with mild cognitive impairment.. GeroScience. https://pubmed.ncbi.nlm.nih.gov/37994989/
  5. Yoshino M, Yoshino J, Kayser BD, et al. (2021). Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women.. Science. https://pubmed.ncbi.nlm.nih.gov/33888596/
  6. Massudi H, Grant R, Braidy N, Guest J, Farnsworth B, Guillemin GJ (2012). Age-associated changes in oxidative stress and NAD+ metabolism in human tissue.. PLoS One. https://pubmed.ncbi.nlm.nih.gov/22848760/
  7. Yi L, Maier AB, Tao R, et al. (2023). The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial.. GeroScience. https://pubmed.ncbi.nlm.nih.gov/36482258/

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.

continue_reading